rs140398462

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001018055.3(BRCC3):​c.681-9A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00216 in 1,166,423 control chromosomes in the GnomAD database, including 34 homozygotes. There are 640 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.012 ( 20 hom., 348 hem., cov: 23)
Exomes 𝑓: 0.0011 ( 14 hom. 292 hem. )

Consequence

BRCC3
NM_001018055.3 intron

Scores

2
Splicing: ADA: 0.00001907
2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.641

Publications

1 publications found
Variant links:
Genes affected
BRCC3 (HGNC:24185): (BRCA1/BRCA2-containing complex subunit 3) This gene encodes a subunit of the BRCA1-BRCA2-containing complex (BRCC), which is an E3 ubiquitin ligase. This complex plays a role in the DNA damage response, where it is responsible for the stable accumulation of BRCA1 at DNA break sites. The component encoded by this gene can specifically cleave Lys 63-linked polyubiquitin chains, and it regulates the abundance of these polyubiquitin chains in chromatin. The loss of this gene results in abnormal angiogenesis and is associated with syndromic moyamoya, a cerebrovascular angiopathy. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 5. [provided by RefSeq, Jun 2011]
MTCP1 (HGNC:7423): (mature T cell proliferation 1) This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure, with a common promoter and 5' exon spliced to two different sets of 3' exons that encode two different proteins. This gene represents the upstream 13 kDa protein that is a member of the TCL1 family. This protein may be involved in leukemogenesis. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-155116702-A-G is Benign according to our data. Variant chrX-155116702-A-G is described in ClinVar as Benign. ClinVar VariationId is 710187.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.012 (1352/112300) while in subpopulation AFR AF = 0.0406 (1254/30914). AF 95% confidence interval is 0.0387. There are 20 homozygotes in GnomAd4. There are 348 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 1352 AD,XL gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001018055.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCC3
NM_001018055.3
MANE Select
c.681-9A>G
intron
N/ANP_001018065.1P46736-2
BRCC3
NM_024332.4
c.756-9A>G
intron
N/ANP_077308.1P46736-1
BRCC3
NM_001242640.2
c.684-9A>G
intron
N/ANP_001229569.1P46736-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCC3
ENST00000330045.12
TSL:1 MANE Select
c.681-9A>G
intron
N/AENSP00000328641.7P46736-2
BRCC3
ENST00000369462.5
TSL:1
c.756-9A>G
intron
N/AENSP00000358474.1P46736-1
BRCC3
ENST00000340647.8
TSL:2
c.684-9A>G
intron
N/AENSP00000344103.4P46736-3

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1350
AN:
112246
Hom.:
20
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0406
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00707
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000939
Gnomad OTH
AF:
0.0119
GnomAD2 exomes
AF:
0.00333
AC:
458
AN:
137596
AF XY:
0.00206
show subpopulations
Gnomad AFR exome
AF:
0.0415
Gnomad AMR exome
AF:
0.00309
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000347
Gnomad OTH exome
AF:
0.00139
GnomAD4 exome
AF:
0.00110
AC:
1162
AN:
1054123
Hom.:
14
Cov.:
24
AF XY:
0.000873
AC XY:
292
AN XY:
334429
show subpopulations
African (AFR)
AF:
0.0342
AC:
872
AN:
25510
American (AMR)
AF:
0.00372
AC:
116
AN:
31171
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18694
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29061
South Asian (SAS)
AF:
0.0000806
AC:
4
AN:
49637
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
38933
Middle Eastern (MID)
AF:
0.000740
AC:
3
AN:
4056
European-Non Finnish (NFE)
AF:
0.0000369
AC:
30
AN:
812565
Other (OTH)
AF:
0.00308
AC:
137
AN:
44496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
36
73
109
146
182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0120
AC:
1352
AN:
112300
Hom.:
20
Cov.:
23
AF XY:
0.0101
AC XY:
348
AN XY:
34482
show subpopulations
African (AFR)
AF:
0.0406
AC:
1254
AN:
30914
American (AMR)
AF:
0.00706
AC:
75
AN:
10628
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3577
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2721
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6117
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000939
AC:
5
AN:
53254
Other (OTH)
AF:
0.0117
AC:
18
AN:
1533
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0156
Hom.:
219
Bravo
AF:
0.0141

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.52
DANN
Benign
0.61
PhyloP100
-0.64
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000019
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140398462; hg19: chrX-154344977; API